Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial

BACKGROUND: The aim of this study is to determine whether adding combination of agents with anti-inflammatory and neurotrophic effects is more efficacious than mood stabilizer alone in improving clinical symptoms, plasma brain-derived neurotrophic factor (BDNF), cytokine levels, and metabolic profil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Bipolar Disord
Autors principals: Lee, Sheng-Yu, Wang, Tzu-Yun, Chen, Shiou-Lan, Chang, Yun-Hsuan, Chen, Po-See, Huang, San-Yuan, Tzeng, Nian-Sheng, Wang, Liang-Jen, Lee, I-Hui, Chen, Kao-Ching, Yang, Yen-Kuang, Hong, Jau-Shyong, Lu, Ru-Band
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049537/
https://ncbi.nlm.nih.gov/pubmed/32115672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40345-019-0174-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars